Live Breaking News & Updates on Pharmaceutical complex
Stay updated with breaking news from Pharmaceutical complex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading investors with more than $15 trillion of assets under management participated in the meeting. RDIF presented 25 pharmaceutical companies that have partnered with the Fund for production
February 15, 2021 • 10:17 am CST (Precision Vaccinations) The Karaganda Pharmaceutical Complex, located in Karaganda, Kazakhstan, announced on February 15, 2021, plans to leverage the Sputnik V vaccine to produce the QazCovid-In Vaccine, reported TASS. This COVID-19 vaccine candidate is currently undergoing a phase 3 clinical study sponsored by Research Institute for Biological Safety Problems. This study's estimated Primary Completion Date is March 31, 2021. On February 1st, Kazakhstan began its coronavirus vaccination campaign by administering the Sputnik V vaccine, which is authorized in about 26 countries. The COVID-19 vaccine Sputnik V (Gam-COVID-Vac) is an adenoviral-based vaccine against the SARS-CoV-2 coronavirus. Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.